These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 34021503)
1. Papillary thyroid microcarcinoma: Is active surveillance always enough? Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503 [TBL] [Abstract][Full Text] [Related]
2. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples. Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151 [TBL] [Abstract][Full Text] [Related]
3. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan. Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377 [No Abstract] [Full Text] [Related]
4. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases. Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963 [No Abstract] [Full Text] [Related]
5. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea. Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447 [TBL] [Abstract][Full Text] [Related]
6. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data]. Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943 [TBL] [Abstract][Full Text] [Related]
7. Active Surveillance for Papillary Thyroid Microcarcinoma in a Population with Restrictive Diagnostic Workup Strategies. Lončar I; van Dijk SPJ; Metman MJH; Lin JF; Kruijff S; Peeters RP; Engelsman AF; van Ginhoven TM Thyroid; 2021 Aug; 31(8):1219-1225. PubMed ID: 33430696 [No Abstract] [Full Text] [Related]
8. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review. Ito Y; Miyauchi A Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250 [No Abstract] [Full Text] [Related]
9. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426 [No Abstract] [Full Text] [Related]
10. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"? Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753 [TBL] [Abstract][Full Text] [Related]
11. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma]. Liu J; Xu C; Yao X; Zhao R; Zhang S Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834 [No Abstract] [Full Text] [Related]
12. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties. Lee S; Bae JS; Jung CK; Chung WY Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560 [TBL] [Abstract][Full Text] [Related]
13. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis. Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148 [TBL] [Abstract][Full Text] [Related]
17. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma. Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258 [TBL] [Abstract][Full Text] [Related]
18. Active surveillance vs. surgery in low-risk papillary thyroid microcarcinoma patients and the risk of loss to follow-up. Saito Y; Matsuzu K; Takami H; Matsui A; Kuga Y; Ohara R; Yoshioka K; Masaki C; Akaishi J; Hames KY; Okamura R; Tomoda C; Suzuki A; Kitagawa W; Nagahama M; Sugino K; Ito K Cancer Med; 2024 Aug; 13(16):e70123. PubMed ID: 39194351 [TBL] [Abstract][Full Text] [Related]
19. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients. Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]